¡¡English |
Chinese |
| Adenovirus |
ÏÙ²¡¶¾ |
| Affected area |
񧂿 |
| Antiviral |
¿¹²¡¶¾ |
| Avian influenza (bird flu) |
ÇÝÁ÷¸Ð |
| Bilateral pulmonary multiple change |
Ë«·Î¶à·¢ÐԸıä |
| Blood count, blood cultures, sputum cultures |
Ѫϸ°û¼ÆÊý£¬ÑªÅàÑø |
| Bronchitis |
Ö§Æø¹ÜÑ× |
| Bronchopneumonia |
Ö§Æø¹Ü·ÎÑ× |
| Carrier |
Я´øÕß |
| Case definition |
Õï¶Ï±ê×¼ |
| Category B notifiable disease |
ÒÒÀഫȾ²¡ |
| Causative virus |
Ö²¡²¡¶¾ |
| Chest X-rays |
ÐØ͸ |
| Chlamydia |
ÒÂÔÌå |
| Chlamydia inclusion body |
ÒÂÔÌå°üº¬Ìå |
| Clinical symptoms |
ÁÙ´²ÌØÕ÷ |
| Community-acquired pneumonia (CAP) |
ÉçÇø»ñµÃÐÔ»òȺÂäÐÔ·ÎÑ× |
| Coronavirus |
¹Ú×´²¡¶¾ |
| Cover your nose and mouth with a tissue when sneezing or coughing |
´òÅçÌç¡¢¿ÈËÔʱÓÃÖ½½íÎæס¿Ú±Ç |
| Cross-tabulation of the various specimens |
Ñù±¾ÁÐ±í½»²æ¶Ô±È |
| Disinfectant or a diluted bleach |
¶¾¼Á»òƯ°×ÈܼÁ |
| Epidemiological study, clinical diagnosis, field investigation and sampling, lab testing |
Á÷Ðв¡Ñ§µ÷²é¡¢ºËʵÕï¶Ï¡¢ÏÖ³¡È¡Ñù¡¢ÊµÑéÊÒ¼ì²é |
| Erythromycin, |
ºìùËØ |
| Azithromycin, |
°¢ÆæùËØ |
| Clarithromycin, |
¿ËÀùËØ |
| Fluoroquinolones and their derivatives (e.g. levofloxacin), |
¶àÎ÷»·ËØ |
| Tetracyclines (e.g. doxycycline) |
£¨È磺ÍÑÑõÍÁùËØ£© |
| Macrolide |
ËÄ»·ËØ £¨Ç¿Á¦Ã¹ËØ£© |
| Etiology |
²¡Ôѧ |
| Expectoration |
¿È̵ |
| Face mask |
¿ÚÕÖ |
| Flake-like infiltrated shadow |
Ƭ״½þÈóÒõÓ° |
| Gene fragment cloned into a bacteria |
¿Ë¡µ½Ï¸¾úµÄ»ùÒòƬ¶Î |
| Genomic sequencing of the virus |
²¡¶¾µÄ»ùÒòÅÅÐò |
| Good personal hygiene |
Á¼ºÃ¸öÈËÎÀÉú |
| Good ventilation |
ͨ·ç |
| Health care settings/facilities |
Ò½ÁÆ»ú¹¹ |
| Hemorrhagic fever |
Á÷ÐÐÐÔ³öѪÈÈ |
| Hospital accident and emergency dept. |
¼±ÕïÊÒ |
| Idiopathic |
×Ô·¢ÐÔ |
| Incubation period |
DZ·üÆÚ |
| Interstitial inflammation change |
¼äÖÊÐÔÑ×Ö¢¸Ä±ä |
| Isolation Order |
¸ôÀëÁî |
| Legionella |
¾üÍžú |
| Leptospriosis |
¹³¶ËÂÝÐýÌ岡 |
| Liquid soap |
Ï´ÊÖÒº |
| lobarpneumonia |
µäÐÍ´óÒ¶ÐÔ·ÎÑ× |
| Mechanical ventilation |
È˹¤ºôÎü |
| Mutate |
Í»±ä |
| Mycoplasma |
Ö§ÔÌå |
| (Neurological syndromes): meningitis, myelitis, encephalitis) |
£¨Éñ¾×ÛºÏÖ¢£©£ºÄÔĤÑס¢¼¹ËèÑס¢ÄÔÑ× |
| Non-specifity |
·ÇÌØÒìÐÔ |
| Notice to Strengthen the Control of Respiratory Diseases in Spring |
¡¶¼ÓÇ¿´º¼¾ºôÎüµÀ´«È¾²¡·ÀÖι¤×÷µÄ֪ͨ¡· |
| Notifiable disease |
·¨¶¨´«È¾²¡ |
| Oxygen supplementation |
²¹Ñõ |
| Para-chlamydia |
¸±±äÒìÐÔÒÂÔÌå |
| Paramyxo virus |
¸±Õ³Òº²¡¶¾ |
| Pathogen |
²¡ÔÌå |
| Pharyngitis |
ÑÊÑ× |
| Pneumococcus |
·ÎÑ×Çò¾ú |
| Primary case |
Ô·¢ÐÔ²¡Àý |
| Imported case |
ÊäÈëÐÔ²¡Àý |
| Prognosis |
Ô¤ºóÕï¶Ï |
| Protective antibody |
±£»¤¿¹Ìå |
| Pulmonary anthrax |
·ÎÌ¿¾Ò |
| Pulmonary plague |
·ÎÊóÒß |
| Quarantine Ordinance |
¼ìÒßÁî |
| Radix Isatidis granules |
°åÀ¶¸ù³å¼Á |
| Reagent |
ÊÔ¼Á |
| Respiratory tract infection |
ºôÎüµÀ¸ÐȾ |
| Ribavirin (a broad spectrum antiviral drug) |
ÈýµªßòºËÜÕ£¬Àû°ÍΤÁÖ(¹ãÆ׿¹ÉúÒ©) (¹ãÆ׿¹ÉúÒ©) |
| Richettsia |
Á¢¿Ë´ÎÌå |
| Seek early medical advice |
Ôç¾ÍÒ½ |
| Sentinel point |
ÉÚµã |
| Serological testing |
ѪÇåѧ¼ì²é |
| Status of the disease |
񧂎 |
| Steroid treatment |
Àà¹Ì´¼ÁÆ·¨ |
| Strain |
²¡¶¾Öê |
| Streptococcus (a bacteria causing classical pneumonia) |
Á´Çò¾ú |
| Surveillance center |
¼à¿ØÖÐÐÄ |
| Technical protocols |
¼¼Êõ·½°¸¡¢¹æ·¶ |
| Transmitted by droplets and direct contact with a patient¡¯s secretions |
½ü¾àÀë·ÉĺͽӴ¥´«²¥ |
| Virology |
²¡¶¾Ñ§ |
